NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Beijing Biosis Healing Biological Technology

Beijing Biosis Healing Biological Technology

Private
BeijingHealthcare & Life Scienceshttps://biosishealing.com/

Last Round

Series D

Jul 4, 2023

Total Funding Raised

$11.51M

Company Overview

Beijing Biosis Healing Biological Technology is a medical supplies company that provides regenerative surgical bio-materials, implantable soft tissue repair mesh, and intelligent minimally invasive surgical instruments.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

implantable biomaterialsSmall Intestinal SubmucosaSISextracellular matrixregenerative medicinesoft tissue repairbiologic meshstaple line reinforcementdural repairhernia repair meshxenograftsurgical staplersdental repair membranebariatric surgery devicesneurosurgery devices

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Beijing Biosis Healing Biological Technology Comps

Public and private peers based on sector, stage, and business model.

Beijing Biosis Healing Biological Technology comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Beijing Biosis Healing Biological Technology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DJul 4, 2023
Series DSep 19, 2022
StrategicDec 30, 2020
StrategicFeb 3, 2020
Series C ExtensionJun 14, 2019
Series C
Jan 9, 2019

Beijing Biosis Healing Biological Technology Investors

Notable investors and investment history

Beijing Biosis Healing Biological Technology investors
InvestorRounds
Qianshan Capital Management Co., Ltd.Series B Extension
NewMargin VenturesStrategic
Dingxin CapitalSeries B, Series A
Ying CapitalSeries D
Guangdong Yueke Financial GroupSeries C Extension
Morgan Stanley ChinaSeries D
Galaxy Yuanhui Investment Co., Ltd.Series C Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 4, 2023

    Raised Series D round with participation from Morgan Stanley China.

  • Sep 19, 2022

    Raised Series D round with Ying Capital participating.

Beijing Biosis Healing Biological Technology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Beijing Biosis Healing Biological Technology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Beijing Biosis Healing Biological Technology's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing
Employee Range9
Year Founded2012
Last FundingJul 4, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.